利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

63 条记录 (耗时 0.024 秒)

    Flexible request and response communications interfaces
    3.
    发明授权
    Flexible request and response communications interfaces 有权
    灵活的请求和响应通信接口

    公开(公告)号：US08239365B2

    公开(公告)日：2012-08-07

    申请号：US12841999

    申请日：2010-07-22

    申请人： Mohammad Salman

    发明人： Mohammad Salman

    IPC分类号： G06F7/00

    CPC分类号： G06F17/30864

    摘要： Methods and systems for database storage allowing subscriber entities to create specialized interfaces for storing different classes of information based on subscribed-defined categories and parameters, allowing for efficient search and retrieval of the information by users using the subscriber-defined categories and parameters. The present technology allows users, such as suppliers, administrators, and others, to add inventory to a database through an interface, search for inventory via an interface, and view results of inventory searches. Inventory requests may be processed using local and remote data stores.

    摘要翻译： 用于数据库存储的方法和系统允许订户实体基于订阅的定义的类别和参数来创建用于存储不同类别的信息的专用接口，允许用户使用订户定义的类别和参数来有效地搜索和检索信息。 本技术允许用户（如供应商，管理员等）通过界面向库中添加库存，通过界面搜索库存，并查看库存搜索结果。 可以使用本地和远程数据存储来处理库存请求。

    Flexible Request and Response Communications Interfaces
    6.
    发明申请
    Flexible Request and Response Communications Interfaces 失效
    灵活的请求和响应通信接口

    公开(公告)号：US20080033965A1

    公开(公告)日：2008-02-07

    申请号：US11833867

    申请日：2007-08-03

    申请人： Mohammad Salman

    发明人： Mohammad Salman

    IPC分类号： G06F17/30

    CPC分类号： G06F17/30864

    摘要： Methods and systems for database storage allowing subscriber entities to create specialized interfaces for storing different classes of information based on subscribed-defined categories and parameters, allowing for efficient search and retrieval of the information by users using the subscriber-defined categories and parameters. A method for processing a search request comprises receiving from a user a set of search terms, retrieving from a database a set of records satisfying the search terms, sending the search terms to one or more suppliers as indicated by supplier links associated with the records, receiving a set of results from the one or more suppliers, and sending the set of results to the user. A method for information storage comprises sending an interface to a supplier over a network, receiving from the supplier a supplier-defined category, a set of supplier-defined parameters associated with the category, and a supplier link, and adding a record comprising the category, the supplier link, and the set of parameters to a database, thereby allowing the database to be searched for the supplier as a provider according to the category and the parameters, and allowing the supplier to be queried via the supplier link for results according to the category and the parameters.

    摘要翻译： 用于数据库存储的方法和系统允许订户实体基于订阅的定义的类别和参数来创建用于存储不同类别的信息的专用接口，允许用户使用订户定义的类别和参数来有效地搜索和检索信息。 一种用于处理搜索请求的方法，包括从用户接收一组搜索项，从数据库中检索满足搜索条件的一组记录，将搜索词发送到由与记录相关联的供应商链接所指示的一个或多个供应商， 从一个或多个供应商接收一组结果，并将该组结果发送给用户。 一种用于信息存储的方法包括：通过网络向供应商发送接口，从供应商接收供应商定义的类别，与该类别相关联的一组供应商定义的参数和供应商链接，以及添加包括该类别的记录 ，供应商链接和一组参数到数据库，从而允许数据库根据类别和参数搜索供应商作为供应商，并允许供应商通过供应商链接查询根据 类别和参数。

    1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists
    7.
    发明申请
    1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists 审中-公开
    1-烷基哌嗪基 - 吡咯烷-2,5-二酮衍生物作为肾上腺素能受体拮抗剂

    公开(公告)号：US20070219216A1

    公开(公告)日：2007-09-20

    申请号：US10575606

    申请日：2004-10-14

    申请人： Nitya Anand ,  Mohammad Salman ,  Somesh Sharma ,  Gobind Kapkoti ,  Praful Gupta ,  Anurag Mishra

    发明人： Nitya Anand ,  Mohammad Salman ,  Somesh Sharma ,  Gobind Kapkoti ,  Praful Gupta ,  Anurag Mishra

    IPC分类号： A61K31/496 ,  A61P13/08 ,  C07D207/408 ,  C07D209/48

    CPC分类号： C07D207/40 ,  C07D207/408 ,  C07D207/416 ,  C07D209/48

    摘要： This invention relates to α1a and/or α1d adrenergic receptor antagonists of formula 1 Compounds disclosed herein can function as α1a and/or α1d adrenergic receptor antagonists and can be used for the treatment of diseases or disorders mediated through α1a and/or α1d adrenergic receptors. Compounds disclosed herein can be used for the treatment of benign prostatic hyperplasia and related symptoms thereof. Compounds disclosed herein can also be used for the treatment of lower urinary tract symptoms associated with or without benign prostatic hyperplasia. The invention also relates to a process for the preparation of compounds disclosed herein, pharmaceutical compositions containing these compounds and the methods of treating diseases or disorders mediated through α1a and/or α1d receptors.

    摘要翻译： 本发明涉及式1的α1α1α和/或α1-1d肾上腺素能受体拮抗剂。本文公开的化合物可以作为α1α和/或α 1d肾上腺素能受体拮抗剂，可用于治疗通过α1α1和/或α1D1肾上腺素能受体介导的疾病或病症。 本文公开的化合物可用于治疗良性前列腺增生及其相关症状。 本文公开的化合物也可用于治疗与或不伴有良性前列腺增生相关的下尿路症状。 本发明还涉及制备本文公开的化合物的方法，含有这些化合物的药物组合物和治疗通过α1a1和/或α1a1介导的疾病或病症的方法 >受体。

    Triazines derivatives as cell adhesion inhibitors
    9.
    发明申请
    Triazines derivatives as cell adhesion inhibitors 审中-公开
    三嗪衍生物作为细胞粘附抑制剂

    公开(公告)号：US20060004005A1

    公开(公告)日：2006-01-05

    申请号：US10949096

    申请日：2004-09-24

    申请人： Viswajanani Sattigeri ,  Mohammad Salman ,  Ramamurthi Narayanan ,  Subhendu Seth ,  Simi Sarin ,  Abhijit Ray ,  Sunanda Dastidar

    发明人： Viswajanani Sattigeri ,  Mohammad Salman ,  Ramamurthi Narayanan ,  Subhendu Seth ,  Simi Sarin ,  Abhijit Ray ,  Sunanda Dastidar

    IPC分类号： A61K31/53

    CPC分类号： C07D251/52 ,  C07D251/16 ,  C07D251/18 ,  C07D251/50 ,  C07D251/54 ,  C07D251/70 ,  C07D405/12 ,  C07D409/12

    摘要： The present invention relates to triazine derivatives as cell adhesion inhibitors. The compounds of this invention can be useful inter alia, for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies, including inflammatory and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis. The compounds can be used to formulate pharmacological compositions, and the methods of treating bronchial asthma, rheumatoid arthritis, multiple sclerosis, type I diabetes, psoriasis, allograft rejection, and other inflammatory and/or autoimmune disorders, using the compounds are also provided herein.

    摘要翻译： 本发明涉及作为细胞粘附抑制剂的三嗪衍生物。 本发明的化合物尤其可用于抑制和预防细胞粘附和细胞粘附介导的病理学，包括炎症和自身免疫性疾病如支气管哮喘，类风湿性关节炎，I型糖尿病，多发性硬化，同种异体移植排斥，牛皮癣。 该化合物可用于配制药物组合物，本文还提供了使用该化合物治疗支气管哮喘，类风湿性关节炎，多发性硬化，I型糖尿病，牛皮癣，同种异体移植排斥和其它炎性和/或自身免疫性疾病的方法。